Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

AMZ became the owner of 22% of its shares

10/14/24 AMEZ

Qeepl has raised the minimum amount of success

10/14/24 OTCI

Moscow Exchange placed the first DFA on a work of art

10/14/24 MOEX

Novabev Group commented on the suspension of the distillery's license

10/14/24 BELU

Bank of Russia registered an additional share issue of Arenadata

10/14/24 DATA

Krystal started bottling sambuca

10/14/24 KLVZ

MTS will transfer ₽3 billion of illegally obtained income to the budget

10/14/24 MTSS

Novatek's gas sales volume in 9 months decreased by 2.3%

10/14/24 NVTK

Bank Saint-Petersburg reported for 9 months of 2024 under RAS

10/14/24 BSPB

Astra's shipments for 9 months increased by 98%

10/14/24 ASTR